Phase 1 Neuroendocrine Tumours Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

ParagangliomaPheochromocytomaSolid Tumor Cancer+19 more

Fundación de investigación HM25 enrolled1 locationNCT06607692

Recruiting

Phase 1

A First-in-Human Study of a Controlled Release Formulation of Lanreotide acetate in healthy male volunteers

AcromegalyNeuroendocrine Tumours

Ascil Australia Pty LTD16 enrolled1 locationACTRN12620001261909

Completed

Phase 1

A First-in-Human Study of a new Controlled Release Formulation of Octreotide acetate in healthy male volunteers

AcromegalyNeuroendocrine Tumours

Ascil Australia Pty Ltd8 enrolled1 locationACTRN12620000108910